Related Experiment Video
Updated: Aug 4, 2025

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
Menopause and diabetes
1Department of Endocrinology, Hospital Cima San José, University of Costa Rica, San Jose, Costa Rica.
Menopause increases type 2 diabetes mellitus (T2DM) risk in women due to hormonal changes and weight gain. Menopause hormone therapy (MHT) may reduce new T2DM diagnoses and improve glycemic control in those with existing T2DM.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Metabolic Disorders
Background:
- Type 2 diabetes mellitus (T2DM) prevalence has tripled in adults, disproportionately affecting women over 50 during menopause.
- Menopause transition involves weight gain, increased abdominal fat, reduced lean mass, and decreased energy expenditure, exacerbating insulin resistance.
- Relative hyperandrogenism, increased pro-inflammatory cytokines, and free fatty acids contribute to metabolic changes during menopause.
Purpose of the Study:
- To review the etiopathogenic factors linking menopause and increased T2DM incidence.
- To examine the impact of menopause on T2DM management.
- To evaluate the role of menopause hormone therapy (MHT) in T2DM prevention and management.
Main Methods:
- Review of current literature on menopause, T2DM, and MHT.
- Analysis of epidemiological data on T2DM prevalence in menopausal women.
- Synthesis of evidence regarding MHT's effects on glycemic control and T2DM risk.
Main Results:
- New evidence suggests MHT significantly reduces new-onset T2DM diagnoses.
- MHT may offer benefits for glycemic control in menopausal women with pre-existing T2DM.
- Individualized, comprehensive management is crucial for menopausal women with or at risk for T2DM.
Conclusions:
- Menopause presents unique challenges for T2DM development and management.
- MHT is a potential therapeutic option for T2DM prevention and management in menopausal women.
- Further research and individualized treatment strategies are essential for this population.
More Related Videos
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
09:44Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Related Concept Videos
Menopause
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
The Endocrine System